Association of CYP2D6*10 (c.100C>T) polymorphisms with clinical outcome of breast cancer after tamoxifen adjuvant endocrine therapy in Chinese population.

Lei, Lei; Wang, Xian; Wu, Xiao-Dan; Wang, Zeng; Chen, Zhan-Hong; Zheng, Ya-Bin; Wang, Xiao-Jia

Lei, Lei; Wang, Xian; Wu, Xiao-Dan; Wang, Zeng; Chen, Zhan-Hong; Zheng, Ya-Bin; Wang, Xiao-Jia.

Afiliação

Lei L; Department of Medical Oncology, Zhejiang Cancer Hospital Hangzhou, Zhejiang Province, P. R. China.
Wang X; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang Province, P. R. China.
Wu XD; Department of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University Hangzhou, Zhejiang Province, P. R. China.
Wang Z; Department of Pharmacy, Zhejiang Cancer Hospital Hangzhou, Zhejiang Province, P. R. China.
Chen ZH; Department of Medical Oncology, Zhejiang Cancer Hospital Hangzhou, Zhejiang Province, P. R. China.
Zheng YB; Department of Medical Oncology, Zhejiang Cancer Hospital Hangzhou, Zhejiang Province, P. R. China.
Wang XJ; Department of Medical Oncology, Zhejiang Cancer Hospital Hangzhou, Zhejiang Province, P. R. China.

Am J Transl Res ; 8(8): 3585-92, 2016.

Article em En | MEDLINE | ID: mdl-27648149

Palavras-chave

CYP2D6; breast cancer; genotyping; tamoxifen

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Transl Res Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google